US Stock MarketDetailed Quotes
BPTH Bio-Path Holdings
- 1.190
- +0.339+39.79%
Close Oct 8 16:00 ET
- 1.050
- -0.140-11.76%
Pre 05:11 ET
3.04MMarket Cap-83P/E (TTM)
1.440High0.961Low65.67MVolume1.280Open0.851Pre Close82.55MTurnover2574.89%Turnover RatioLossP/E (Static)2.55MShares16.00052wk High2.35P/B3.04MFloat Cap0.84652wk Low--Dividend TTM2.55MShs Float23999.988Historical High--Div YieldTTM56.23%Amplitude0.846Historical Low1.256Avg Price1Lot Size
Bio-Path Holdings Stock Forum
Sign in to post a comment
$Bio-Path Holdings (BPTH.US)$
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Bio-Path Holdings (NASDAQ:BPTH) has announced a $4.0 million private placement priced at-the-market under Nasdaq rules. The company will issue and sell 4,597,702 shares of common stock (or equivalents), along with series A and B warrants to purchase additional shares. The purchase price is set at $0.87 per share, with warrants exercisable at $1.00 per share. The off...
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Bio-Path Holdings (NASDAQ:BPTH) has announced a $4.0 million private placement priced at-the-market under Nasdaq rules. The company will issue and sell 4,597,702 shares of common stock (or equivalents), along with series A and B warrants to purchase additional shares. The purchase price is set at $0.87 per share, with warrants exercisable at $1.00 per share. The off...
1
$Bio-Path Holdings (BPTH.US)$ +39% 🚀
🚨 Initiates Obesity Therapeutic Program
⇒ BP1001-A
⇒ first non-cancer application of DNAbilize technology
🚨 Initiates Obesity Therapeutic Program
⇒ BP1001-A
⇒ first non-cancer application of DNAbilize technology
$Bio-Path Holdings (BPTH.US)$ piss of shit
7
$Bio-Path Holdings (BPTH.US)$ Could be a good one if the results are successful in Q4 !
1
$Bio-Path Holdings (BPTH.US)$
Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of Obesity
Bio-Path Holdings (NASDAQ:BPTH) has announced two significant developments:
1. Initiation of a therapeutic program to develop BP1001-A for treating obesity and related metabolic diseases, marking the first non-cancer application of their DNAbilize® technology.
2. Completion of enrollment in the third dosing cohort of the ongoing Phase 1/1b clinical trial evaluating BP1002 fo...
Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of Obesity
Bio-Path Holdings (NASDAQ:BPTH) has announced two significant developments:
1. Initiation of a therapeutic program to develop BP1001-A for treating obesity and related metabolic diseases, marking the first non-cancer application of their DNAbilize® technology.
2. Completion of enrollment in the third dosing cohort of the ongoing Phase 1/1b clinical trial evaluating BP1002 fo...
2
$Bio-Path Holdings (BPTH.US)$ granted patent, can go upward?
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
152498441 : your thoughts?